Evidence map›Paper›PMID 34959456›Full record

ArticlePharmaceutics2021

New Intracellular Peptide Derived from Hemoglobin Alpha Chain Induces Glucose Uptake and Reduces Blood Glycemia.

Renée N O Silva, Ricardo P Llanos, Rosangela A S Eichler, Thiago B Oliveira, Fábio C Gozzo, William T Festuccia, Emer S Ferro

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Trial
  2. Neurolysin Knockout Mice in a Diet-Induced Obesity Model.International journal of molecular sciences · 2023
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Renée N O SilvaDepartment of Pharmacology, Biomedical Science Institute, University of São Paulo, São Paulo 05508-000, SP, Brazil.ORCID 0000-0002-9068-6207
Ricardo P LlanosDepartment of Pharmacology, Biomedical Science Institute, University of São Paulo, São Paulo 05508-000, SP, Brazil.
Rosangela A S EichlerDepartment of Pharmacology, Biomedical Science Institute, University of São Paulo, São Paulo 05508-000, SP, Brazil.
Thiago B OliveiraPhysiology and Biophysics, Biomedical Science Institute, University of São Paulo, São Paulo 05508-000, SP, Brazil.
Fábio C GozzoInstitute of Chemistry, State University of Campinas, Campinas 13083-862, SP, Brazil.
William T FestucciaPhysiology and Biophysics, Biomedical Science Institute, University of São Paulo, São Paulo 05508-000, SP, Brazil.ORCID 0000-0003-4769-0806
Emer S FerroDepartment of Pharmacology, Biomedical Science Institute, University of São Paulo, São Paulo 05508-000, SP, Brazil.ORCID 0000-0003-1651-9192
Universidade de São Paulo · BRUniversidade Estadual de Campinas (UNICAMP) · BR

Funding

National Council for Scientific and Technological Development 445363/2014-2, 400944/2014-6 and 302809/2016-3São Paulo Research Foundation 2015/07273-8São Paulo Research Foundation 2016/04000-3
6 · The paper itself

Abstract

Intracellular peptides were shown to derive from proteasomal degradation of proteins from mammalian and yeast cells, being suggested to play distinctive roles both inside and outside these cells. Here, the role of intracellular peptides previously identified from skeletal muscle and adipose tissues of C57BL6/N wild type (WT) and neurolysin knockout mice were investigated. In differentiated C2C12 mouse skeletal muscle cells, some of these intracellular peptides like insulin activated the expression of several genes related to muscle contraction and gluconeogenesis. One of these peptides, LASVSTVLTSKYR (Ric4; 600 µg/kg), administrated either intraperitoneally or orally in WT mice, decreased glycemia. Neither insulin (10 nM) nor Ric4 (100 µM) induced glucose uptake in adipose tissue explants obtained from conditional knockout mice depleted of insulin receptor. Ric4 (100 µM) similarly to insulin (100 nM) induced Glut4 translocation to the plasma membrane of C2C12 differentiated cells, and increased GLUT4 mRNA levels in epididymal adipose tissue of WT mice. Ric4 (100 µM) increased both Erk and Akt phosphorylation in C2C12, as well as in epididymal adipose tissue from WT mice; Erk, but not Akt phosphorylation was activated by Ric4 in tibial skeletal muscle from WT mice. Ric4 is rapidly degraded in vitro by WT liver and kidney crude extracts, such a response that is largely reduced by structural modifications such as N-terminal acetylation, C-terminal amidation, and substitution of Leu8 for DLeu8 (Ac-LASVSTV[DLeu]TSKYR-NH2; Ric4-16). Ric4-16, among several Ric4 derivatives, efficiently induced glucose uptake in differentiated C2C12 cells. Among six Ric4-derivatives evaluated in vivo, Ac-LASVSTVLTSKYR-NH2 (Ric4-2; 600 µg/kg) and Ac-LASVSTV[DLeu]TSKYR (Ric4-15; 600 µg/kg) administrated orally efficiently reduced glycemia in a glucose tolerance test in WT mice. The potential clinical application of Ric4 and Ric4-derivatives deserves further attention.

Indexed as

bioactive peptidesdiabetesglucose uptakeinsulin signalingpeptide drug discovery

Identifiers

PMID34959456
PMCPMC8708875
OpenAlexW4200497726

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.